These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33227394)

  • 1. CUL4B promotes aggressive phenotypes of renal cell carcinoma via upregulating c-Met expression.
    Chen S; Wang Y; Chen L; Xia Y; Cui J; Wang W; Jiang X; Wang J; Zhu Y; Sun S; Zou Y; Gong Y; Shi B
    Int J Biochem Cell Biol; 2021 Jan; 130():105887. PubMed ID: 33227394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-Met is a prognostic marker and potential therapeutic target in clear cell renal cell carcinoma.
    Gibney GT; Aziz SA; Camp RL; Conrad P; Schwartz BE; Chen CR; Kelly WK; Kluger HM
    Ann Oncol; 2013 Feb; 24(2):343-349. PubMed ID: 23022995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of Cullin1 is increased in renal cell carcinoma and promotes cancer cell proliferation, migration, and invasion.
    Ping JG; Wang F; Pu JX; Hou PF; Chen YS; Bai J; Zheng JN
    Tumour Biol; 2016 Sep; 37(9):12823-12831. PubMed ID: 27449035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma.
    Zhou L; Liu XD; Sun M; Zhang X; German P; Bai S; Ding Z; Tannir N; Wood CG; Matin SF; Karam JA; Tamboli P; Sircar K; Rao P; Rankin EB; Laird DA; Hoang AG; Walker CL; Giaccia AJ; Jonasch E
    Oncogene; 2016 May; 35(21):2687-97. PubMed ID: 26364599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cullin 4B regulates cell survival and apoptosis in clear cell renal cell carcinoma as a target of microRNA-217.
    Yang HF; Wang ZL; Mao TT; Liu JC
    Kaohsiung J Med Sci; 2021 Feb; 37(2):121-127. PubMed ID: 33022894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CUL4B promotes metastasis and proliferation in pancreatic cancer cells by inducing epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway.
    He YM; Xiao YS; Wei L; Zhang JQ; Peng CH
    J Cell Biochem; 2018 Jul; 119(7):5308-5323. PubMed ID: 29274277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CUL4B promotes gastric cancer invasion and metastasis-involvement of upregulation of HER2.
    Qi M; Jiao M; Li X; Hu J; Wang L; Zou Y; Zhao M; Zhang R; Liu H; Mi J; Zhang L; Liu L; Gong Y; Han B
    Oncogene; 2018 Feb; 37(8):1075-1085. PubMed ID: 29106389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UBE2T promotes proliferation and regulates PI3K/Akt signaling in renal cell carcinoma.
    Hao P; Kang B; Li Y; Hao W; Ma F
    Mol Med Rep; 2019 Aug; 20(2):1212-1220. PubMed ID: 31173226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenomedullin blockade suppresses sunitinib-resistant renal cell carcinoma growth by targeting the ERK/MAPK pathway.
    Gao Y; Li J; Qiao N; Meng Q; Zhang M; Wang X; Jia J; Yang S; Qu C; Li W; Wang D
    Oncotarget; 2016 Sep; 7(39):63374-63387. PubMed ID: 27556517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CUL4B renders breast cancer cells tamoxifen-resistant via miR-32-5p/ER-α36 axis.
    Wang Y; Pan X; Li Y; Wang R; Yang Y; Jiang B; Sun G; Shao C; Wang M; Gong Y
    J Pathol; 2021 Jun; 254(2):185-198. PubMed ID: 33638154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Met inhibitors with novel binding mode show activity against several hereditary papillary renal cell carcinoma-related mutations.
    Bellon SF; Kaplan-Lefko P; Yang Y; Zhang Y; Moriguchi J; Rex K; Johnson CW; Rose PE; Long AM; O'Connor AB; Gu Y; Coxon A; Kim TS; Tasker A; Burgess TL; Dussault I
    J Biol Chem; 2008 Feb; 283(5):2675-83. PubMed ID: 18055465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular RNA hsa_circ_0054537 sponges miR-130a-3p to promote the progression of renal cell carcinoma through regulating cMet pathway.
    Li R; Luo S; Zhang D
    Gene; 2020 Sep; 754():144811. PubMed ID: 32464246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CUL4B Promotes Breast Carcinogenesis by Coordinating with Transcriptional Repressor Complexes in Response to Hypoxia Signaling Pathway.
    Huang W; Zhang J; Huo M; Gao J; Yang T; Yin X; Wang P; Leng S; Feng D; Chen Y; Yang Y; Wang Y
    Adv Sci (Weinh); 2021 May; 8(10):2001515. PubMed ID: 34026424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of ALPK2 blocks development and progression of renal cell carcinoma.
    Jiang J; Han P; Qian J; Zhang S; Wang S; Cao Q; Shao P
    Exp Cell Res; 2020 Jul; 392(2):112029. PubMed ID: 32330508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulation of the miR-194-CUL4B negative feedback loop drives tumorigenesis in non-small-cell lung carcinoma.
    Mi J; Zou Y; Lin X; Lu J; Liu X; Zhao H; Ye X; Hu H; Jiang B; Han B; Shao C; Gong Y
    Mol Oncol; 2017 Mar; 11(3):305-319. PubMed ID: 28164432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction of YBX1 with G3BP1 promotes renal cell carcinoma cell metastasis via YBX1/G3BP1-SPP1- NF-κB signaling axis.
    Wang Y; Su J; Wang Y; Fu D; Ideozu JE; Geng H; Cui Q; Wang C; Chen R; Yu Y; Niu Y; Yue D
    J Exp Clin Cancer Res; 2019 Sep; 38(1):386. PubMed ID: 31481087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scutellarin inhibits human renal cancer cell proliferation and migration via upregulation of PTEN.
    Deng W; Han W; Fan T; Wang X; Cheng Z; Wan B; Chen J
    Biomed Pharmacother; 2018 Nov; 107():1505-1513. PubMed ID: 30257368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CUL4B/miR-33b/C-MYC axis promotes prostate cancer progression.
    Zhao M; Qi M; Li X; Hu J; Zhang J; Jiao M; Bai X; Peng X; Han B
    Prostate; 2019 Apr; 79(5):480-488. PubMed ID: 30609075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CUL4B enhances the malignant phenotype of esophageal squamous cell carcinoma by suppressing TGFBR3 expression.
    Gong Q; Wang Y; Zhu K; Bai X; Feng T; Sun G; Wang M; Pan X; Qin C
    Biochem Biophys Res Commun; 2023 Oct; 676():58-65. PubMed ID: 37487438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CUL4B-miR-372/373-PIK3CA-AKT axis regulates metastasis in bladder cancer.
    Liu X; Cui J; Gong L; Tian F; Shen Y; Chen L; Wang Y; Xia Y; Liu L; Ye X; Wang M; Liu G; Jiang B; Shao C; Zou Y; Gong Y
    Oncogene; 2020 Apr; 39(17):3588-3603. PubMed ID: 32127645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.